This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Health Hope Pharma Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Sameer Urgaonkar: Innovator in Cancer Drug Absorption
Introduction
Sameer Urgaonkar is a notable inventor based in Williamsville, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the absorption of cancer chemotherapy drugs. His work focuses on innovative solutions that can potentially improve treatment outcomes for cancer patients.
Latest Patents
Sameer Urgaonkar holds 1 patent for his invention titled "Polymorphisms of HM30181 mesylate." This patent describes various polymorphisms of HM30181, specifically polymorphisms B, D, E, F, G, H, I, J, K, L, and M. These polymorphisms are designed to improve the absorption of chemotherapy drugs, such as paclitaxel, thereby enhancing their effectiveness in cancer treatment.
Career Highlights
Urgaonkar is currently associated with Health Hope Pharma Ltd, where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to improving patient care through scientific advancements.
Collaborations
He collaborates with esteemed colleagues, including Michael P Smolinski and Johnson Yiu-Nam Lau, who contribute to his research and development efforts.
Conclusion
Sameer Urgaonkar's innovative work in the field of cancer treatment exemplifies the impact of scientific research on healthcare. His contributions are paving the way for improved therapeutic options for patients battling cancer.